The Citric Acid Cycle: Harvesting Electrons

Strip away the chemistry and the citric acid cycle has one real job: harvest high-energy electrons from carbon fuel. A two-carbon acetyl fragment enters and condenses onto a four-carbon receiver to make six carbons. Around the ring we lose two carbons as carbon dioxide and shrink back down, and as we do, we capture electrons in NADH and FADH2 and squeeze out a single ATP. Notice the carbon bookkeeping along the rim, six to five to four, and notice how every step that drops a carbon also banks reducing power. That single ATP is a rounding error next to the three NADH and one FADH2 waiting to feed the next stage.

Think of the cycle as a two-stage machine. In stage one, oxidation, two carbons are introduced as an acetyl group onto oxaloacetate to form citrate, and that six-carbon citrate undergoes two oxidative decarboxylations, burning off two molecules of carbon dioxide. That is the burn-carbon half. Stage two is regeneration, rebuilding the catalyst: the remaining backbone is reworked step by step until oxaloacetate is restored and ready to accept the next acetyl group. The dividing line in the middle is the stage boundary. Both halves matter, because both generate the high-energy electrons that ultimately power ATP synthesis in oxidative phosphorylation downstream.

Here is a puzzle worth sitting with: oxygen never appears anywhere in the citric acid cycle, yet the cycle is strictly aerobic. Why? The cycle produces NADH and FADH2, but it can only keep running if it gets NAD+ and FAD back. Those carriers are regenerated only when the electron transport chain reoxidizes them, and the electron transport chain hands its electrons to oxygen at the very end. Remove oxygen and the chain backs up, the carriers stay reduced, NAD+ and FAD never return, and the cycle grinds to a halt. So the cycle depends on oxygen indirectly, through the carriers it must recycle.

Before we run the cycle, ask where the fuel comes from, because acetyl-CoA is the common entry point for everything we eat. Carbohydrates become glucose, which glycolysis and the pyruvate dehydrogenase complex convert through pyruvate into acetyl-CoA. Fats are chopped down by beta-oxidation directly into acetyl-CoA. And many amino acids, after deamination removes their nitrogen, also funnel into acetyl-CoA. Three very different macronutrients, three different routes, one shared product. That convergence is the whole point: the citric acid cycle is the central hub where all fuel types are ultimately oxidized, so whatever you burn, it ends up here.

Here is the subtle bookkeeping that trips students up. Two carbons enter as acetyl-CoA and two leave as carbon dioxide, so it is tempting to assume the carbons that came in are the ones that go out. They are not. Follow the colors: the carbons released as carbon dioxide on the first turn come from oxaloacetate, the four-carbon receiver, not from the acetyl group you just added. The acetyl carbons stay in the molecule and only leave on later turns. The accounting balances overall, but the identity of the atoms is scrambled. Focus on the principle here rather than the exact structures, which are simplified.

Why would the cell physically organize some cycle enzymes into complexes? Picture the alternative. Without channeling, each intermediate is released into the surrounding solution and must randomly diffuse to find the next enzyme, which is slow and lets product drift away. With substrate channeling, intermediates are handed directly from one active site to the next, like passing a baton. That buys you three things: speed, because diffusion is no longer the bottleneck; selectivity, because the intermediate cannot wander off into competing pathways; and efficiency, because nothing is lost. This is a recurring design principle in metabolism, and the cycle exploits it where it counts.

Let us pause at the halfway mark and tally what the cycle has already extracted by the time we reach succinyl-CoA. Two carbons have left as carbon dioxide. Two molecules of NADH have been captured. And one high-energy thioester bond has been formed in succinyl-CoA, primed to make ATP in the very next step. We are only halfway around the ring and the cell has already pulled out most of the value. That is the takeaway: oxidation front-loads the payoff. The second half mainly regenerates oxaloacetate while picking up a bit more reducing power on the way.

Think of the cell as financially literate, constantly converting between currencies. The citric acid cycle closes its books at one GTP per turn — the only cash-in-hand payout — and carries the rest of its earnings forward as NADH and FADH2, reducing power that still has to be sold. The electron transport chain is where that sale happens, converting each NADH into roughly two and a half ATP and each FADH2 into about one and a half, by reducing oxygen. So the cycle banks the electrons, and the next pathway liquidates them. Keep that handoff in mind; the real ATP windfall comes downstream.

The regulation of the cycle is not arbitrary; it tracks the cell's energy balance directly. In a high-energy state, when ATP and NADH are abundant, the cell does not need to burn more fuel, so these molecules act as signals that slow the cycle down at its committed, irreversible steps. In a low-energy state, when ADP piles up and ATP is scarce, the brakes come off and the cycle speeds up to regenerate ATP. The same logic coordinates pyruvate dehydrogenase upstream, so feeding into the cycle and running the cycle stay matched. Supply chases demand, and the controls sit exactly where flux commits.

The citric acid cycle is not just textbook metabolism; broken versions of it drive disease. Mutations in several cycle enzymes, including succinate dehydrogenase, fumarase, and isocitrate dehydrogenase, are linked to cancer. The most striking example is mutant isocitrate dehydrogenase, which gains an abnormal activity and produces 2-hydroxyglutarate, an oncometabolite. That molecule does not feed metabolism; it rewires gene expression and pushes cells toward unrestrained growth. Other defects nudge cancer cells toward aerobic glycolysis instead of full oxidation. The lesson is that a central metabolic pathway is also a signaling node, and when it fails, the consequences reach all the way to the genome.

Plants and many bacteria run a clever variant called the glyoxylate cycle, which lets them do something animals cannot: build carbohydrate from fat. The trick is bypassing the two decarboxylation steps that would otherwise burn off carbon as carbon dioxide. By skipping those losses, the pathway conserves carbon, allowing two acetyl-CoA units to be woven into a four-carbon molecule that can exit toward gluconeogenesis. Trace the bypass through glyoxylate and back to malate. This is exactly why oil-rich seeds, like sunflower seeds, can mobilize stored fat to grow a seedling before it can photosynthesize. Conserve the carbon, and you can make sugar from fat.

Let us close by counting reducing equivalents per glucose, because the cycle only makes sense in the larger ledger. Glycolysis gives two NADH. Pyruvate oxidation gives two more. The citric acid cycle, run twice for the two pyruvates, contributes six NADH plus two FADH2. Add it up and we are sitting on ten NADH and two FADH2, all queued and waiting. None of that is ATP yet; it is stored electrical potential. In the next lecture we cash these carriers in through the electron transport chain, converting them into roughly thirty to thirty-two ATP. That is where the energy investment finally pays off.